GLP1 Medication

Thinking About GLP-1 Weight-Loss Medication? Start With These Questions

Weight-loss medications have become a major part of the health conversation. Between social media testimonials and headlines about medications like semaglutide and tirzepatide, it can be difficult to understand what these treatments could mean for your own health.

If you’re curious about medical weight management, a conversation with your primary care provider is a good place to start. The goal is to understand your options, weigh the benefits and risks, and create a plan that fits your needs.

What are GLP-1 medications?

GLP-1 receptor agonists mimic a hormone involved in blood sugar regulation and appetite. Semaglutide belongs to this class. Tirzepatide acts on both GLP-1 and another hormone pathway called GIP. These medications have different approved uses depending on the specific product, including type 2 diabetes and chronic weight management.

Although these treatments often appear together in online discussions, they are not interchangeable. Your provider can explain which options, if any, are appropriate for you.

Although these treatments often appear together in online discussions, they are not interchangeable. Your provider can explain which options, if any, are appropriate for you.

Am I a candidate for medication?

Prescription weight-management medications may be considered for adults with a body mass index, or BMI, of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure or type 2 diabetes. Meeting those criteria does not automatically mean medication is the right choice. Your medical history, current prescriptions, pregnancy plans, and other health factors also matter.

Come prepared to discuss what you have already tried, the challenges you face, and what you hope treatment will help you accomplish.

What should I know about side effects?

Common side effects can include nausea, vomiting, diarrhea, and constipation. Certain medications also carry warnings about pancreatitis, gallbladder problems, and dehydration-related kidney injury. Some are contraindicated for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.

Safety guidance continues to evolve. In November 2026, the FDA announced labeling changes concerning a potential increased risk of a rare optic nerve condition called NAION. Sudden vision loss or new visual disturbances require immediate medical attention.

Ask your provider which symptoms to report and how your treatment will be monitored.

How do nutrition and exercise fit into treatment?

Medication works best alongside changes in eating habits and physical activity. It does not replace them.

As appetite decreases, getting adequate nutrition still matters. Current obesity care guidance emphasizes sufficient protein and muscle-strengthening activity to help minimize muscle loss during weight reduction. Your provider can help you identify an appropriate approach and discuss whether support from a registered dietitian would be useful.

What should I ask at my appointment?

A few questions can help make the conversation more productive:

  • What are my treatment options, including approaches without medication?
  • How will we measure progress?
  • What side effects or medication interactions should we discuss?
  • What will treatment and follow-up cost?
  • What is the long-term plan?

Start a conversation about your health

Restora Medical provides adult primary and preventive care in Orlando, with an approach that considers medical history, metabolic health, and everyday factors such as nutrition, sleep, activity, and stress.

If weight management is on your mind, schedule an appointment with Restora Medical to discuss your goals and explore appropriate next steps.

This article provides general education and does not replace personalized medical advice.